Peripheral Induction of Inhibitory Brain Circuits to Treat Tourette's: Pilot
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 34
- 试验地点
- 2
- 主要终点
- Change in Tic Frequency During Rhythmic MNS (vs. Arrhythmic MNS)
研究概览
简要总结
Results from the University of Nottingham suggested that rhythmic median nerve stimulation (MNS) improves tic symptoms in Tourette syndrome (TS). The investigators will (1) provide a first replication of their study, (2) test the hypothesized electrophysiological mechanism and rule out a placebo effect as cause for the symptomatic benefit, and (3) gather information on the duration of effect after the end of stimulation and on individual characteristics that predict improvement with simulation. Completion of these Aims will give a clear go/no-go signal for a future clinical trial of chronic MNS delivered by a yet-to-be-developed wristwatch-style device.
NOTE: This study is not intended to evaluate a specific device for future use. Rather it is a study to determine the action of pulsed electrical stimulation on tic symptoms and to gain early evidence of effectiveness. This is a non-significant risk device study.
详细描述
Chronic tic disorders (CTD), including Tourette syndrome (TS), are associated with a substantially reduced quality of life. Medication treatments are no more than 50-60% effective in randomized controlled trials, and are often discontinued due to unacceptable side effects. Behavioral therapies require ability to participate in therapy and a specially trained therapist, but weekly visits to psychologists are impractical for many Americans, especially in rural areas. Patients strongly desire new treatment options.
In June, 2020, Stephen Jackson's group at the University of Nottingham published a fascinating report in Current Biology on a potential novel treatment for tics. The radical new idea arose from observations associating movement inhibition with 8-14 Hz activity in motor cortex. They first showed that rhythmic 12 Hz peripheral stimulation of the median nerve evoked synchronous contralateral EEG activity over primary sensorimotor cortex, whereas arrhythmic stimulation at the same mean rate did not. As hypothesized, median nerve stimulation (MNS) at 12 Hz created small but statistically significant effects on initiation of voluntary movements. Importantly, they also demonstrated that this stimulation did not meaningfully impair concentration, suggesting that the effect did not operate through simple distraction. They went on to test 10 Hz MNS in 19 TS patients, and demonstrated using blinded video ratings a significant reduction in tic number and severity during 1-minute stimulation epochs vs 1-minute no-stimulation epochs. They noted that in some participants, benefit lasted beyond the end of the stimulation epoch. Videos accompanying the publication showed dramatic benefit during MNS in some subjects. Although the authors appropriately noted the steps needed to generalize these results to clinical practice, news reports already have led a number of TS patients to contact them asking for treatment. The Nottingham group has referred such inquiries from the U.S. to me as leader of our Wash.U. Tourette Association of America (TAA) Center of Excellence.
The hypotheses of this project are that the tic benefits reported by the Nottingham investigators are replicable, that they are specific to rhythmic stimulation, which alone entrained cortical activity, rather than to a placebo effect, and that they endure past the end of stimulation.
This project (a) will replicate the Nottingham findings using identical methods, and (b) will test rhythmic MNS against a placebo treatment (arrhythmic MNS at the same mean frequency). It also will gather additional preliminary data needed for a future R01 application, including response and tolerability with longer (5-minute) stimulation blocks, and the duration of benefit after the end of a stimulation block.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Crossover
- 主要目的
- Treatment
- 盲法
- Triple (Participant, Investigator, Outcomes Assessor)
盲法说明
The stimulation pulses will be triggered by a computer program which will provide either rhythmic or arrhythmic MNS at the same mean rate throughout a given study session. A programmer who does not interact with the participants uses a stimulation order table created by a true random number generator to select the "day 1" and "day 2" program for each participant in advance. Participants and the investigator are blind to stimulation order and stimulation type. Audiovisual recordings of tics will be rated by a reviewer who will additionally be blind to time (first vs. second stimulation session).
入排标准
- 年龄范围
- 15 Years 至 64 Years（Child, Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Age 15-64 inclusive at initial screening visit
- •Informed consent by adult subject; assent by child and informed consent by guardian
- •Current Tourette's Disorder or Persistent (Chronic) Tic Disorder according to the criteria in the Diagnostic and Statistical Manual of Mental Disorders, 5th Edition: DSM-5
- •At least 1 tic per minute (average) during the first 5-min. baseline video session on the first visit (as scored during the session by the investigator)
排除标准
- •Unable to complete study procedures for any reason
- •Has an implanted device that could be affected by electrical current
- •Pregnancy known to participant or (for children) to the parent
- •Known or suspected primary genetic syndrome (e.g. Down syndrome, Fragile X)
- •Intellectual disability (known, or likely from history and examination)
- •Head trauma with loss of consciousness for more than 5 minutes
- •Significant neurologic disease, not counting TS (exceptions include febrile seizures or uncomplicated migraine)
- •Severe or unstable systemic illness
- •Factors (such as exaggerated signs) that in the judgment of the principal investigator make the video recording or YGTSS an inaccurate assessment of tic severity
- •Judged by investigator to be unlikely to complete study procedures or to return for later visits
- •Change in somatic or psychotherapeutic treatment in the 2 weeks preceding the first stimulation visit
- •Planned change in somatic or psychotherapeutic treatment between the 2 stimulation visits
结局指标
主要结局
Change in Tic Frequency During Rhythmic MNS (vs. Arrhythmic MNS)
时间窗: During 5-minute MNS stimulation on or off blocks 0, 5, 6, 7, 8 and 9
The number of tics per minute is assessed by an expert rater blind to condition and time point. Change in tic frequency from baseline (stimulation off) is compared between 5-minute MNS-on epochs on the rhythmic vs. the arrhythmic day. Subjects who do not complete both stimulation visits will not be included in this analysis. The hypothesized change is greater improvement (off to on) with rhythmic vs. arrhythmic stimulation. This analysis includes the first six 5-minute blocks on each MNS day (i.e., the blocks that all participants complete). MNS was administered throughout blocks 6 and 8 only. Tic frequency in block 0 (baseline, before any stimulation) on the same day was a covariate in the statistical model.
Change in Tic Severity From When MNS is Turned Off
时间窗: During the 1-minute on and 1-minute off blocks of rhythmic MNS stimulation (total 4 blocks)
Severity is rated on a 5-point scale for each occurrence of any tic. The scale is the Intensity item from the Yale Global Tic Severity Scale \[YGTSS\], which uses integer scores from 0 (no tics) to 5 (severe intensity). Mean tic severity was compared in on vs. off 1-minute stimulation epochs on the rhythmic MNS day. This analysis replicates that of Study 3 in the Morera Maiquez et al 2020 citation.
Change in Tic Severity During Rhythmic MNS (vs. Arrhythmic MNS)
时间窗: During 5-minute MNS stimulation on or off blocks 0, 5, 6, 7, 8 and 9
Overall tic severity for each 5-minute block is rated once on a 5-point scale by an expert blind to condition and time point. The scale is the Intensity item from the Yale Global Tic Severity Scale \[YGTSS\], which uses integer scores from 0 (no tics) to 5 (severe intensity). Change in tic severity from baseline (stimulation off) is compared between 5-minute MNS-on epochs on the rhythmic vs. the arrhythmic day. Subjects who do not complete both stimulation visits will not be included in this analysis. The hypothesized change was greater improvement (off to on) with rhythmic vs. arrhythmic stimulation. This analysis includes the first six 5-minute blocks on each MNS day (i.e., the blocks that all participants complete). MNS was administered throughout blocks 6 and 8 only. Tic frequency in block 0 (baseline, before any stimulation) on the same day was a covariate in the statistical model.
Change in Tic Frequency From When MNS is Turned Off
时间窗: During the 1-minute on and 1-minute off blocks of rhythmic MNS stimulation (total 4 blocks)
The number of tics per minute is assessed by an expert rater blind to condition and time point. Mean tic frequency was compared in on vs. off 1-minute stimulation epochs on the rhythmic MNS day. This analysis replicates that of Study 3 in the Morera Maiquez et al 2020 citation, who reported tics in the last 40 seconds of the block to minimize carryover effects. A Mixed Models Analysis was used to test statistical significance; it included a factor for possible within-day carryover effect and used a logarithmic transformation for tic count. Data reported here have been back-transformed to the number of tics in the last 40 s of the stimulation blocks.
次要结局
- Rating of Therapeutic Effect Using the CGI Efficacy Index(5-25 minutes after the end of stimulation at each study visit up to 1 month)
- Change in Tic Severity After MNS Ends(up to 20 minutes after the end of stimulation at each study visit up to 1 month)
- CGI-I, Investigator(5-25 minutes after the end of stimulation at each study visit up to 1 month)
- Rating of Discomfort Using the CGI Efficacy Index (Edited)(5-25 minutes after the end of stimulation at each study visit up to 1 month)
- CGI-I, Participant(5-25 minutes after the end of stimulation at each study visit up to 1 month)
- VAS (Visual Analog Scale) Rating of Premonitory Urge Severity(At the end of each 5-min. MNS on or off block through block 9, at each study visit)
- Blindedness Assessment(5-25 minutes after the end of stimulation at each study visit up to 1 month)
研究者
Kevin J. Black, M.D.
Principal Investigator
Washington University School of Medicine